Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Browse by collection
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Browse by collection
Archive
Authors
About
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Quantitative Immunofluorescence
Email alerts
Quantitative Immunofluorescence
Objective measurement and clinical significance of IDO1 protein in hormone receptor-positive breast cancer
Daniel E.
Carvajal-Hausdorf
,
Nikita
Mani
,
Vamsidhar
Velcheti
,
Kurt A.
Schalper
,
David L.
Rimm
Journal for ImmunoTherapy of Cancer
Dec 2017,
5
(1)
81;
DOI:
10.1186/s40425-017-0285-7
Clinical significance of PD-L1 protein expression on tumor-associated macrophages in lung cancer
Kurt Alex
Schalper
,
Daniel
Carvajal-Hausdorf
,
Joseph
McLaughlin
,
Vamsidhar
Velcheti
,
Lieping
Chen
,
Miguel
Sanmamed
,
Roy S
Herbst
,
David L
Rimm
Journal for ImmunoTherapy of Cancer
Dec 2015,
3
(Suppl 2)
P415;
DOI:
10.1186/2051-1426-3-S2-P415
Special collections
COVID-19
(44)
Editor's choice
JITC
Basic Tumor Immunology
(538)
Case Reports
(191)
Clinical Trials Monitor
(17)
Clinical/Translational Cancer Immunotherapy
(941)
Commentary/Editorials
(142)
Computational I-O
(4)
COVID-19 and Cancer Immunotherapy
(10)
Emerging Immunotherapeutic Agents
(5)
Guidelines and Consensus Statements
(55)
Guidelines and Consensus Statements
(50)
Imaging and Immunotherapy
(8)
Immune Cell Therapies and Immune Cell Engineering
(213)
Immune Checkpoints - Beyond PD-1
(8)
Immune Checkpoints Beyond PD-1 Series
(8)
Immune Monitoring Technology Primers
(12)
Immunotherapy Biomarkers
(407)
Liquid Biopsies
(9)
Microbial-Based Cancer Immunotherapy
(4)
Oncolytic and Local Immunotherapy
(143)
Reviews
(239)
Open access
(4871)
Press releases
